| Lung Neuroendocrine Carcinoma studied in …STUDIED_INderived200 of 1,113show all (up to 200) |
|---|
| → studied in | NCT01242072Phase 1 · completed Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03391362NA · active not recruiting Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04402788Phase 2/Phase 3 · suspended Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472517Phase 3 · recruiting DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509034Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707895Phase 1/Phase 2 · not yet recruiting DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02146170recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226999Phase 2/Phase 3 · recruiting Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476287Phase 2 · recruiting Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843940Phase 1/Phase 2 · not yet recruiting A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595931Phase 1 · active not recruiting M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460977Phase 1 · recruiting A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037758Phase 1 · recruiting A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624204Phase 3 · active not recruiting Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06799286Phase 1 · completed A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07465757Phase 2 · recruiting A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07559929Phase 1/Phase 2 · recruiting A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155174Phase 2 · recruiting A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177937Phase 1 · recruiting A Study of DXC014 in Patients With Advanced Solid Tumors. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365241Phase 3 · recruiting A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278479Phase 1/Phase 2 · recruiting Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429087Phase 1 · active not recruiting A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153239Phase 3 · completed Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05578326Phase 2 · recruiting Study of Trilaciclib and Lurbinectidin · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06773910Phase 2 · active not recruiting BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665856Phase 3 · completed Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04342429NA · recruiting Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287775Phase 1/Phase 2 · recruiting Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07459634Phase 2 · recruiting A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07625644Phase 3 · recruiting BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778316Phase 3 · recruiting Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06077500Phase 1 · active not recruiting DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06873555Phase 1/Phase 2 · recruiting A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07080242Phase 1 · recruiting Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585750Phase 1/Phase 2 · recruiting The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05990738Phase 1 · active not recruiting DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06612151Phase 3 · active not recruiting A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer (TAISHAN-302) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061535Phase 2 · recruiting Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819591Phase 2 · not yet recruiting Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516070Phase 2 · active not recruiting Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804644Phase 3 · active not recruiting Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05403723Phase 1 · suspended Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06449209Phase 2 · active not recruiting Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07113691Phase 1 · recruiting Iadademstat + SBRT With Atezo in ES-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218146Phase 3 · recruiting A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07325136Phase 1/Phase 2 · recruiting A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06646276Phase 3 · recruiting A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06657222Phase 1/Phase 2 · recruiting First in Human Study of TUB-030 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161388recruiting Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07564401Phase 1/Phase 2 · recruiting A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815223Phase 2 · recruiting A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514497Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06830694Phase 2 · recruiting Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05091567Phase 3 · active not recruiting A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361395Phase 1 · active not recruiting First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780137Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005128Phase 3 · active not recruiting A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07192991recruiting Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America · condition mapped ONTOLOGY_EXACT · 1,113 trials mapped (442 active) | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640932Phase 2 · not yet recruiting Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803848Phase 2 · recruiting Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04699838Phase 2 · active not recruiting Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509333NA · recruiting MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802821Phase 3 · not yet recruiting A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07535359available Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783477Phase 1 · recruiting A Study of Armored CAR T Cells in People With Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798947Phase 2 · not yet recruiting A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712355Phase 3 · recruiting Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07795411not yet recruiting Prospective Multiomic Analysis in Small-Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796100Phase 3 · not yet recruiting A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057791Phase 2 · recruiting Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064466Phase 2/Phase 3 · active not recruiting Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03811002Phase 3 · active not recruiting Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05924841Phase 2 · recruiting A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478043Phase 2 · completed A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726148Phase 1/Phase 2 · recruiting Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04209595Phase 1/Phase 2 · completed PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561645Phase 2 · not yet recruiting A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488923Phase 1 · recruiting A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07654400Phase 2 · recruiting A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02046733Phase 2 · completed Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739758Phase 3 · recruiting A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963867Phase 1 · recruiting A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179069Phase 1 · recruiting A Study of ZL-1310 in Subjects With Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07531095Phase 1 · recruiting Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623369Phase 1 · recruiting A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142696Phase 1/Phase 2 · active not recruiting A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06922539Phase 1 · recruiting Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728361Phase 2 · completed Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095505Phase 2 · recruiting A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745323Phase 2 · active not recruiting A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06768307Phase 2 · recruiting Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02769962Phase 1/Phase 2 · terminated Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03782207completed A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924101Phase 2 · completed Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688894recruiting The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S] · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199741Phase 1/Phase 2 · recruiting PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05552846NA · recruiting Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801834Phase 3 · recruiting Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155200Phase 1/Phase 2 · recruiting Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759856Phase 2 · recruiting NK Cells Plus ICI for SCLC Maintenance · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06807632Phase 1 · recruiting A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07752875Phase 1/Phase 2 · not yet recruiting A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203210Phase 3 · recruiting A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468656not yet recruiting SCLC Tarlatamab Blood Collection · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879978Phase 1 · active not recruiting A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06486428active not recruiting Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07075627withdrawn A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545954Phase 1 · recruiting DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744256Phase 1/Phase 2 · recruiting Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744698Phase 4 · recruiting Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03662074Phase 2 · terminated Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896503Phase 2 · active not recruiting Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07402343Phase 2 · recruiting Tarlatamab for SCLC Brain Metastases · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05957510Phase 2 · active not recruiting Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339059Phase 2 · recruiting Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713732Phase 1 · not yet recruiting TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616624Phase 1/Phase 2 · terminated ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095583Phase 3 · recruiting Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06992609Phase 3 · active not recruiting Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502300Phase 3 · recruiting A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728955Phase 3 · not yet recruiting A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931626Phase 1 · recruiting Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882058Phase 2 · recruiting DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022757Phase 1/Phase 2 · terminated Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06437509Phase 2 · recruiting A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05060016Phase 2 · active not recruiting A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06131840Phase 1 · recruiting A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04826341Phase 1/Phase 2 · completed A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07253142Phase 2 · recruiting A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07559786Phase 2 · recruiting A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043872Phase 3 · active not recruiting Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05652686Phase 1/Phase 2 · recruiting A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734004Phase 1/Phase 2 · active not recruiting A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05889546recruiting Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628376recruiting TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05787587Phase 1 · active not recruiting A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698054Phase 2 · not yet recruiting Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02635009Phase 2/Phase 3 · completed Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06502977Phase 2 · active not recruiting Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174583Phase 1/Phase 2 · recruiting A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04487756Phase 1/Phase 2 · completed Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049966Phase 1 · completed Atezolizumab in Large Cell Neuroendocrine Carcinoma · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06103682NA · recruiting LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07242547Phase 2 · recruiting Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416695Phase 1 · recruiting A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745689Phase 2 · active not recruiting Study of AZD2811 + Durvalumab in ES-SCLC · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358676Phase 2 · recruiting A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07423585Phase 2 · recruiting Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677787NA · recruiting DLL3-Targeted PET/CT in Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598306Phase 1 · recruiting Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07149363Phase 2 · recruiting Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670442not yet recruiting Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227546Phase 2 · active not recruiting MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07366658Phase 1 · recruiting Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652736recruiting A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887159Phase 2 · completed A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046923Phase 1 · recruiting A Study of LY4175408 in Participants With Advanced Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130255Phase 1 · terminated GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257264Phase 1 · active not recruiting A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007325early Phase 1 · not yet recruiting Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153055Phase 1/Phase 2 · recruiting Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07208773Phase 1/Phase 2 · recruiting A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07508852Phase 1/Phase 2 · recruiting 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638546Phase 2 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702880Phase 2 · completed A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07473128Phase 3 · recruiting Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453154Phase 1/Phase 2 · completed Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05683977active not recruiting A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06501976Phase 2 · active not recruiting An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05257551recruiting Tempus Small Cell Lung Cancer Observational Study (Sculptor) · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957314NA · recruiting A Study of Hospital-at-Home for People Receiving Tarlatamab · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646106Phase 1 · recruiting THE-0504 in Patients With Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04155034Phase 3 · active not recruiting S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728230Phase 1/Phase 2 · active not recruiting Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07091305Phase 2 · recruiting A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419076Phase 2 · recruiting A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07517198Phase 1 · recruiting Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07267000NA · recruiting EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636226Phase 2/Phase 3 · not yet recruiting QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07637513Phase 3 · not yet recruiting Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06497530Phase 2 · recruiting Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623642Phase 2 · not yet recruiting A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. · condition mapped ALIAS · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632209Phase 2 · not yet recruiting Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04334941Phase 2 · active not recruiting Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker · condition mapped CURATED_BROADER · 1,113 trials mapped (442 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |